 |
Minimal deposit $50 Exclusive promotion |
Our score |
0% commission |
Are you looking to buy Bausch Health stocks? Chech our Reportlab with an in-depth review, check prices, statistics and see if buying this stock is interesting right now. This article will help you buy NYSE:BHC! and analyze the company to see if this stock might be an interesting option to invest in. We will enlighten you about Bausch Health stocks and how to buy and use them. Click on the button to start reading the review right now or scroll down for real time statistics about this company.
Bausch Health Companies Inc. develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through four segments: Bausch + Lomb/International, Salix, Ortho Dermatologics, and Diversified Products. The Bausch + Lomb/International segment offers products with a focus on the vision care, surgical, and consumer and ophthalmology Rx products in the United States; and Solta products, branded and generic pharmaceutical products, OTC products, and medical device products, and Bausch + Lomb products in Canada, Europe, Asia, Australia, Latin America, Africa, and the Middle East. The Salix segment provides gastroenterology products in the United States. The Ortho Dermatologics segment offers dermatological products in the United States; and Solta medical aesthetic devices internationally. The Diversified Products segment provides pharmaceutical products in the areas of neurology and other therapeutic classes, as well as generic and dentistry products in the United States. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. is headquartered in Laval, Canada.
Average volume
4.42 million shs
MARKET CAP
$10.10 billion
Stock exchange
NYSE
Buy this stock!
|
NAME
|
TICKER
|
INDUSTRY
|
SECTOR
|
VOLUME
|
BUY THIS STOCK NOW
|
|---|---|---|---|---|---|
|
NYSE:BHC
|
Pharmaceutical preparations
|
Medical
|
32,858 shs
|
Below is a quick guide on how to buy NYSE:BHC stocks safe, fast and around the world in less than five minutes.
Step 1: Open an account with eToro – eToro is the best broker to buy Bausch Health shares in the world as you won’t pay any commissions. To do this, visit the eToro website and open an account, it is 100% safe and they offer a huge amount of stocks.
Step 2: Upload your ID – As per KYC regulations eToro will ask you to upload a copy of your passport or driver’s license.
Step 3: Deposit Funds – Deposit some money into your newly created eToro account. You can choose between wire transfer, e-wallet or debit/credit card or Paypal.
Step 4: Buy Bausch Health – Search for “”NYSE:BHC”” and click on the “”Trade”” button. Enter the total amount of your investment (minimum $50) and confirm the order by clicking the “”Open Trade”” button. And that’s it: you have just bought Bausch Health stocks with 0% commission!.
1 | | Minimal deposit $50 Exclusive promotion | Our score 10 ★★★★★ | 0% commission |
13 Wall Street analysts have issued “buy,” “hold,” and “sell” ratings for Bausch Health Companies in the last year. There are currently 6 hold ratings and 7 buy ratings for the stock. The consensus among Wall Street analysts is that investors should “buy” Bausch Health Companies stock.
Wall Street analysts have given Bausch Health Companies a “Buy” rating, but there may be better short-term opportunities in the market. Some of Reportlab’s past winning trading ideas have resulted in 5-15% weekly gains. Reportlab just released five new trading ideas, but Bausch Health Companies wasn’t one of them. Reportlab thinks five stocks may be even better buys in the how to buy stocks guide.
1 | | Minimal deposit $50 Exclusive promotion | Our score 10 ★★★★★ | 0% commission |
2 |  | Minimal deposit $50 Exclusive promotion | Our score 10 ★★★★★ | 0% commission |
3 |  | Minimal deposit $50 Exclusive promotion | Our score 10 ★★★★★ | 0% commission |
It can be difficult to navigate through all the outdated and incorrect information related to purchasing NYSE:BHC stocks. We believe that stocks should be accessible for all, which is why we’ve created this handy guide on where to buy Bausch Health stocks with a step by step approach.
You’ll need to register with a broker, in these times you can’t go without once and it’s crucial to use a regulated broker that’s allowed to operate there, otherwise, you risk losing funds. eToro is one such broker, and one of the best brokers to buy Bausch Health stocks with 0% comission, to sign up just click on open account in the following table or compare other options.
Because eToro is a regulated platform, you’ll need to complete the KYC process, this is standard practice and only takes a couple of minutes. You’ll need to provide a photo ID (passport, driving licence) and proof of address (utility bill, bank statement).
Once you’ve signed up and verified your account, you’ll need to deposit funds. eToro accepts credit/debit cards, bank transfers, and also e-wallets. So whatever your preference there will be something for you.
Now that you’ve funded your eToro account, just type “NYSE:BHC stocks” into the search bar at the top of the screen and press “trade”.
All that’s left is to buy some NYSE:BHC stock. Simply enter the amount you want to purchase and hit the “buy” button. The amount you bought will be automatically credited to your account where you can monitor its performance.
All in all, NYSE:BHC is an incredibly interesting company that has the potential to solve some major issues in the business space. After reading this guide you should know how to buy this investment using the best broker or platform. We recommend eToro to anyone looking for a regulated, easy-to-use, fully-featured broker to buy Bausch Health stocks. As with any broker or online platform, it’s crucial you set up 2FA when using their tools as it ensures your funds are completely safe.
Bausch Health Companies is scheduled to release its next quarterly earnings announcement on Wednesday, February 24th 2021.
View our earnings forecast for Bausch Health Companies.
Bausch Health Companies will be holding an earnings conference call on Wednesday, February 24th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.
Bausch Health Companies Inc. (NYSE:BHC) issued its quarterly earnings results on Sunday, November, 8th. The company reported $1.32 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $1.02 by $0.30. The firm earned $2.14 billion during the quarter, compared to analyst estimates of $2.05 billion. Bausch Health Companies had a positive trailing twelve-month return on equity of 173.20% and a negative net margin of 23.92%. Bausch Health Companies’s revenue was down 3.2% compared to the same quarter last year. During the same period in the previous year, the company posted $1.21 EPS.
View Bausch Health Companies’ earnings history.
Bausch Health Companies’ stock was trading at $18.45 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, BHC shares have increased by 55.0% and is now trading at $28.60.
Launched in 2006, eToro is, in our opinion, without a doubt the best broker for buying NYSE:BHC stocks in the world. The onboarding process is simple, it’s designed to make sure even those new to the stock market are ready to start investing the shortest amount of time possible. As a regulated platform you gain several benefits, most importantly, you know they’re not going to run off with your hard-earned money./
Over 95% of client funds are kept offline, in cold storage, which is crucial for any broker that manages your assets. Regardless of how secure a platform is meant to be, we recommend using 2FA to add an additional layer of security to your account.
eToro offers users a range of features to start investing as quickly as possible. They have a relatively unique feature called copy trading, which lets you earn a passive income by mirroring experienced traders, this allows you to start earning profit quickly, and gives you a better understanding of the strategies used by professionals. Additionally, eToro allows users to invest in managed portfolios, a managed portfolio being a variety of similar assets grouped together, allowing you to diversify your account, reducing any potential risk. For those with previous trading experience, you can invest in markets outside of stocks, as eToro allows users to trade ETFs, commodities, crypto and indices. If you already invest outside of the stock market space this can be very useful, as it allows you to manage all your investments in just one place.
Bausch Health Companies updated its fourth quarter 2020 After-Hours earnings guidance on Tuesday, January, 12th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $2.2 billion, compared to the consensus revenue estimate of $2.12 billion.
13 Wall Street analysts have issued 1-year price objectives for Bausch Health Companies’ stock. Their forecasts range from $17.00 to $50.00. On average, they expect Bausch Health Companies’ share price to reach $29.23 in the next year. This suggests a possible upside of 2.2% from the stock’s current price.
View analysts’ price targets for Bausch Health Companies or view top-rated stocks among Wall Street analysts.
CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 68% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
Bausch Health Companies saw a decline in short interest in the month of December. As of December 31st, there was short interest totaling 13,970,000 shares, a decline of 16.9% from the December 15th total of 16,810,000 shares. Based on an average daily trading volume, of 3,660,000 shares, the days-to-cover ratio is currently 3.8 days. Currently, 4.0% of the company’s stock are short sold.
View Bausch Health Companies’ Short Interest.
Bausch Health Companies’ management team includes the following people:
Mr. Joseph C. Papa, CEO & Chairman (Age 66, Pay $4.86M)
Mr. Paul S. Herendeen, Exec. VP & CFO (Age 65, Pay $2.75M)
Ms. Christina M. Ackermann, Exec. VP, Gen. Counsel & Head of Commercial Operations (Age 56, Pay $1.51M)
Mr. Thomas J. Appio, Pres & Co-Head Bausch + Lomb/International (Age 59, Pay $2.09M)
Mr. Osama A. Eldessouky, Sr. VP, Controller & Chief Accounting Officer (Age 49)
Dr. Robert F. Butz, VP of Medical & Scientific Affairs
Mr. Arthur J. Shannon, Sr. VP and Head of Investor Relations & Communications
Mr. Michael McMyne, VP of Sales
Ms. Stacey Williams, VP of Marketing
Ms. Kelly Webber, Sr. VP & Chief HR Officer
43 employees have rated Bausch Health Companies CEO Joseph C. Papa on Glassdoor.com. Joseph C. Papa has an approval rating of 97% among Bausch Health Companies’ employees. This puts Joseph C. Papa in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.
Some companies that are related to Bausch Health Companies include BeiGene (BGNE), Alexion Pharmaceuticals (ALXN), Astellas Pharma (ALPMY), Shiseido (SSDOY), Takeda Pharmaceutical (TKPYY), Genmab A/S (GMAB), Genmab A/S (GNMSF), MERCK Kommanditgesellschaft auf Aktien (MKGAF), CureVac (CVAC), UCB (UCBJF), Catalent (CTLT), Alnylam Pharmaceuticals (ALNY), Horizon Therapeutics Public (HZNP), Royalty Pharma (RPRX) and BioMarin Pharmaceutical (BMRN).
View all of BHC’s competitors.
1 | | Minimal deposit $50 Exclusive promotion | Our score 10 ★★★★★ | 0% commission |
Based on aggregate information from Reportlab watchlists, some companies that other Bausch Health Companies investors own include Gilead Sciences (GILD), Micron Technology (MU), Constellation Software (CSU), Intact Financial (IFC), NVIDIA (NVDA), Netflix (NFLX), Alibaba Group (BABA), Tesla (TSLA), Advanced Micro Devices (AMD) and Bank of America (BAC).
Bausch Health Companies trades on the New York Stock Exchange (NYSE) under the ticker symbol “BHC.”
Bausch Health Companies’ stock is owned by a variety of retail and institutional investors. Top institutional investors include BlackRock Inc. (0.61%), FIL Ltd (0.42%), Swiss National Bank (0.36%), Private Management Group Inc. (0.31%), Sumitomo Mitsui Trust Holdings Inc. (0.27%) and Gamco Investors INC. ET AL (0.22%). Company insiders that own Bausch Health Companies stock include Christina Ackermann, Eschenbach Andrew C Von, Holdings LP Valueact, John Paulson, Joseph C Papa, Mark C Mckenna, Schutter Richard U De and William D Humphries.
View institutional ownership trends for Bausch Health Companies.
BHC stock was sold by a variety of institutional investors in the last quarter, including Sumitomo Mitsui Trust Holdings Inc., Intact Investment Management Inc., Aperio Group LLC, BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp, Gabelli Funds LLC, Swiss National Bank, Terril Brothers Inc., and Creative Planning.
View insider buying and selling activity for Bausch Health Companies or view top insider-selling stocks.
BHC stock was acquired by a variety of institutional investors in the last quarter, including Ieq Capital LLC, FIL Ltd, Parkside Investments LLC, Gamco Investors INC. ET AL, Paradigm Capital Management Inc. NY, M&G Investment Management Ltd., Kestra Advisory Services LLC, and Pendal Group Limited. Company insiders that have bought Bausch Health Companies stock in the last two years include Christina Ackermann, Eschenbach Andrew C Von, Holdings LP Valueact, John Paulson, Joseph C Papa, Schutter Richard U De, and William D Humphries.
View insider buying and selling activity for Bausch Health Companies or or view top insider-buying stocks.
Shares of BHC can be purchased through any online brokerage account. Popular online brokerages with access to the stock market include Interactive Brokers Review, eToro Review, DEGiro Review, AvaTrade Review, IG Markets Review, IC Markets Review, CMC Markets Review, Admiral Markets Review and many more. Read one of the reviews to find out everything about the broker and start buying stocks now.
At Reportlab.org we want to make sure that you have all the most relevant information about buying stocks. We bring you the best guides about the stock market with personal reviews, background information, platform reviews, how to’s and more. Want to get other information? Then check out the OTC stocks, NASDAQ stocks, NYSE stocks, LON stocks, FRA stocks, ETR stocks, EPA stocks, TSX stocks or Amex stocks. Looking for more detailed info like 5g stocks, biotech stocks, gold stocks and other information out of our reportlab.
How to buy Bausch Health stocks?
The safest and easiest way to buy NYSE:BHC stocks is by using a regulated broker like eToro or DEGiro. You can open an account with the platform, make a deposit and buy this stock in under 5 minutes from start to finish.
Opening an account with one of these brokers is a smart move, they have been active for more then 10 years, are very safe to use and they have the best platform for novice and experienced traders. If you want to learn more then we suggest you to read our eToro or DeGiro guides.
Where to buy Bausch Health stock?
You will first want to find a licensed broker that supports Bausch Health stock. One of our favourite brokers, eToro for example, allows you to make investments into this asset from just $25 and only charges you the spread. Another option is using a regulated broker like DEGIRO or Interactive Brokers. You can open an account with these brokers and start buying or trading NYSE:BHC stocks in a safe and complete environment.
Is NYSE:BHC stock a good investment?
As with any other asset, there is an element of risk associated with buying NYSE:BHC stocks. Therefore, you will want to study the market and make a decision based on your financial standing and the risk you are willing to take.
Is Bausch Health stock safe to invest in?
All stocks are volatile, or affected by market circumstances. The case with NYSE:BHC is no different, with its price fluctuating dramatically within short periods. As such, if the market goes against you, then you will end up facing a loss. We advice you to do research first before investing in Bausch Health stock.
How do you trade Bausch Health stocks?
You can trade stocks by first opening an account with a regulated platform and making a deposit in US dollars, EUROs or other currency. Next, search for Bausch Health stock and choose from a buy or sell order – depending on whether you think the stock asset will rise or fall in value. If you speculated on NYSE:BHC stocks correctly, you will have made a profit. The size of your trading profit will ultimately be determined by your stake and at what percentage your position grew.
How to sell Bausch Health stock?
To sell your NYSE:BHC stocks investment, you can sign in to your broker account and cash out directly from within your portfolio. If you have stored the stocks elsewhere, you will first have to transfer them to a third-party provider or broker to cash out.
What is the best Bausch Health stock trading platform?
eToro, is a top-rated platform for beginners, albeit, it charges significantly lower fees. For example, there are no fees to deposit with a debit/credit card and you only need to cover the spread when trading NYSE:BHC stock.
Stephen knows a lot about financial products and in particular has a great passion for the stock markets and its participants. We hope that the information provided will help you. Something not quite clear? Please leave your questions or comments at the bottom of the page.
| Our score ★★★★★ | |
| Our score ★★★★★ | |
| Our score ★★★★★ |
Newsletter
Recent News
| |
Our score |
0% commission |
Realtime Stocks & Crypto data
Notifications, Tips & News
Best Stocks & Crypto Guides
Online Broker & Exchange Reviews
Reportlab Finance is purely an informative website and in no case implies investment advice. All investments carry risks and you can lose all your investments. Do not invest money that you cannot afford to lose.
Reportlab Finance
38 Holburn Lane
Heckfield Green
IP21 0UB
United Kingdom
Copyright © 2022 Reportlab.Finance | All rights reserved.
